195 related articles for article (PubMed ID: 23810977)
1. 18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.
Cohen C; Mekinian A; Uzunhan Y; Fauchais AL; Dhote R; Pop G; Eder V; Nunes H; Brillet PY; Valeyre D; Fain O; Soussan M
Autoimmun Rev; 2013 Sep; 12(11):1109-14. PubMed ID: 23810977
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of
Keraen J; Blanc E; Besson FL; Leguern V; Meyer C; Henry J; Belkhir R; Nocturne G; Mariette X; Seror R
Arthritis Rheumatol; 2019 Jul; 71(7):1147-1157. PubMed ID: 30615273
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.
van Ginkel MS; Arends S; van der Vegt B; Nijland M; Spijkervet FKL; Vissink A; Kroese FGM; Glaudemans AWJM; Bootsma H
Rheumatology (Oxford); 2023 Oct; 62(10):3323-3331. PubMed ID: 36759907
[TBL] [Abstract][Full Text] [Related]
4. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.
Shimizu M; Okamura K; Kise Y; Takeshita Y; Furuhashi H; Weerawanich W; Moriyama M; Ohyama Y; Furukawa S; Nakamura S; Yoshiura K
Arthritis Res Ther; 2015 Aug; 17(1):223. PubMed ID: 26298875
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT in multisystem Sjögren syndrome.
Sharma P; Chatterjee P
Clin Nucl Med; 2015 May; 40(5):e293-4. PubMed ID: 25674865
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland 18F-FDG-PET/CT uptake patterns in Sjögren's syndrome and giant cell arteritis patients.
Grootelaar RGJ; van Ginkel MS; Nienhuis PH; Arends S; Pieterman RM; Brouwer E; Bootsma H; Glaudemans AWJM; Slart RHJA
Clin Exp Rheumatol; 2023 Dec; 41(12):2428-2436. PubMed ID: 38079331
[TBL] [Abstract][Full Text] [Related]
9. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
[TBL] [Abstract][Full Text] [Related]
10. Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.
Jimenez-Royo P; Bombardieri M; Ciurtin C; Kostapanos M; Tappuni AR; Jordan N; Saleem A; Fuller T; Port K; Pontarini E; Lucchesi D; Janiczek R; Galette P; Searle G; Patel N; Kershaw L; Gray C; Ratia N; van Maurik A; de Groot M; Wisniacki N; Bergstrom M; Tarzi R
Rheumatology (Oxford); 2021 May; 60(5):2396-2408. PubMed ID: 33221921
[TBL] [Abstract][Full Text] [Related]
11. Elastographic ultrasound: an additional image tool in Sjögren's syndrome.
Kimura-Hayama E; Criales-Vera S; Azpeitia-Espinosa L; Pacheco-Molina C; Reyes E; Lima G; Hernandez-Ramirez D; Llorente L; Hernandez-Molina G
Int J Rheum Dis; 2018 Jun; 21(6):1293-1300. PubMed ID: 29624878
[TBL] [Abstract][Full Text] [Related]
12. FDG PET-CT demonstration of Sjogren's sialoadenitis.
Jadvar H; Bonyadlou S; Iagaru A; Colletti PM
Clin Nucl Med; 2005 Oct; 30(10):698-9. PubMed ID: 16166849
[TBL] [Abstract][Full Text] [Related]
13. Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome.
Vitali C; Tavoni A; Viegi G; Begliomini E; Agnesi A; Bombardieri S
Ann Rheum Dis; 1985 Jul; 44(7):455-61. PubMed ID: 4026406
[TBL] [Abstract][Full Text] [Related]
14. Physiologic facial muscle uptake on 18F-FDG PET/CT by chewing-like habitual movement in patient with Sjögren syndrome.
Lee DH; Yoon JK; Yoon SH; Lee SJ; An YS
Clin Nucl Med; 2015 Mar; 40(3):268-9. PubMed ID: 25608147
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.
Malmström M; Seppä A; Konttinen YT; Helve T; Reitamo S
Rheumatol Int; 1983; 3(1):1-5. PubMed ID: 6604304
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
20. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
